Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.49 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.38 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 5/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
| ▸ | YAP1 | P46937 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL433280 | 0.89 | FFAR1 (0.54) | FFAR1PPARAPPARDYAP1 | |
| SCHEMBL433281 | 0.89 | FFAR1 (0.54) | FFAR1PPARAPPARDYAP1 | |
| SCHEMBL22668070 | 0.85 | FFAR1 (0.51) | FFAR1PPARATDP1 | |
| SCHEMBL22668554 | 0.82 | FFAR1 (0.62) | FFAR1 | |
| SCHEMBL10258787 | 0.78 | FFAR1 (0.59) | FFAR1PPARAPPARDPPARG | |
| SCHEMBL15239313 | 0.78 | FFAR1 (0.59) | FFAR1PPARAPPARDPPARG | |
| SCHEMBL436122 | 0.77 | FFAR1 (0.60) | FFAR1TDP1 | |
| SCHEMBL436123 | 0.77 | FFAR1 (0.60) | FFAR1TDP1 | |
| SCHEMBL22668329 | 0.77 | FFAR1 (0.46) | FFAR1PPARATDP1PPARDPPARG | |
| SCHEMBL435343 | 0.76 | FFAR1 (0.57) | FFAR1PPARATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2595952-B1 | AGONISTS OF GPR40 | CONNEXIOS LIFE SCIENCES PVT LTD (IN) | 2020-11-18 | — | — | EP | disclosed |